Search research articles
Contact Us
Filters
Showing results (11-20 of 241) with videos related to
Page
of 25
Sort By:
Metabolism: Clinical and Experimental
|
November 15, 2000
Addressing the insulin secretion defect: a logical first-line approach
J E Gerich
Bailliere'S Clinical Endocrinology and Metabolism
|
July 1, 1993
Control of glycaemia
J E Gerich
American Family Physician
|
March 1, 1977
Somatostatin
J E Gerich
Metabolism: Clinical and Experimental
|
November 1, 1976
Alpha cell function in diabetes mellitus
J E Gerich
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1986
Rationale for inhibition of growth hormone secretion in the management of the diabetic patient
J E Gerich
Diabetologia
|
August 1, 1991
Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?
J E Gerich
Advances in Internal Medicine
|
January 1, 1977
Somatostatin: diabetes and acromegaly
J E Gerich
American Family Physician
|
August 1, 1977
Diabetic control and the late complications of diabetes
J E Gerich
Metabolism: Clinical and Experimental
|
November 1, 1976
Metabolic effects of long-term somatostatin infusion in man
J E Gerich
Metabolism: Clinical and Experimental
|
September 1, 1978
Somatostatin modulation of glucagon secretion and its importance in human glucose homeostasis
J E Gerich
Page
of 25
Search research articles
Search
Showing results (11-20 of 241) with videos related to
Sort By:
Page
of 25
Metabolism: Clinical and Experimental
|
November 15, 2000
Addressing the insulin secretion defect: a logical first-line approach
J E Gerich
Bailliere'S Clinical Endocrinology and Metabolism
|
July 1, 1993
Control of glycaemia
J E Gerich
American Family Physician
|
March 1, 1977
Somatostatin
J E Gerich
Metabolism: Clinical and Experimental
|
November 1, 1976
Alpha cell function in diabetes mellitus
J E Gerich
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1986
Rationale for inhibition of growth hormone secretion in the management of the diabetic patient
J E Gerich
Diabetologia
|
August 1, 1991
Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?
J E Gerich
Advances in Internal Medicine
|
January 1, 1977
Somatostatin: diabetes and acromegaly
J E Gerich
American Family Physician
|
August 1, 1977
Diabetic control and the late complications of diabetes
J E Gerich
Metabolism: Clinical and Experimental
|
November 1, 1976
Metabolic effects of long-term somatostatin infusion in man
J E Gerich
Metabolism: Clinical and Experimental
|
September 1, 1978
Somatostatin modulation of glucagon secretion and its importance in human glucose homeostasis
J E Gerich
Page
of 25